Generics 20

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Sorafenib manufacturers

20 products found

Filters

20 products found

sorafenib

Tablets 200 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, US
Manufacturer #15017
A pharmaceutical manufacturer based in the EU that has been active for 20+ years. The main therapeutic areas include oncology. The company's production lines are GMP-compliant.

Manufacturer usually replies in 5 days

sorafenib

Tablets, film coated 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Saudi Arabia , Vietnam
Manufacturer #519

Manufacturer usually replies in 6 days

sorafenib

Tablets Upon request

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #10033
A pharmaceutical manufacturer based in Europe specializes in development and manufacturing for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. The main therapy areas include the immune system, CNS, and cardiovascular system. The main dosage forms include solid oral and injectable.

Manufacturer usually replies in 11 days

sorafenib

Tablets, film coated 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Bulgaria , Costa Rica
Manufacturer #361
It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

sorafenib

Tablets, film coated 200 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

Manufacturer usually replies in 4 days

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21024

Manufacturer usually replies in 2 days

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20510

Manufacturer usually replies in 2 days

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19664

Manufacturer usually replies in 5 days

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530

Manufacturer usually replies in 4 days

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #16099

Manufacturer usually replies in 6 days

sorafenib

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30013

Manufacturer usually replies in 2 days

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #19588

Manufacturer usually replies in 7 days

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Unavailable markets
Peru
Manufacturer #17417

Manufacturer usually replies in 6 days

sorafenib

Tablets, film coated 200mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16199
One of the largest and biggest names in the pharmaceutical industry. The company has a network all across the globe. They are known to be partnering with similar companies for a very long time.

Manufacturer usually replies in 9 days

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #17753

Manufacturer usually replies in 10 days

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Outdated
Country of origin
India
GMP approvals
WHO
Manufacturer #31073

Manufacturer usually replies in 6 days

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30830

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #28571

Manufacturer usually replies in nan days

sorafenib

Tablets 200 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Manufacturer #1356

Want to view all 20 products? Create your free account today!

Sorafenib

Sorafenib is a kinase inhibitor used in the treatment of primary kidney cancer called advanced renal cell carcinoma, advanced primary liver cancer called hepatocellular carcinoma, FLT3- ITD positive AML and radioactive iodine resistant advanced thyroid cancer. The survival rates amongst patients who are administered were 60% in the 1st year, 35% in the 2nd year, and 26% in the third year. A wide-ranging study conducted in Asia pacific also proved the efficacy of this treatment.
Sorafenib is primarily marketed as Nexavar. But given its use around the world, it is manufactured and sold by suppliers and labellers around the world. Bayer and Onyx Pharmaceuticals developed and marketed Sorafenib. Sorafenib was approved by the U.S. Food and Drug Administration in 2005 and received European Commission’s marketing authorization in 2006.

Forms and Dosage

Sorafenib is sold as a tablet of 200 mg strength. The dosage in the treatment of Renal Cell Carcinoma as Indicated is 400 mg every 12 hours or twice a day. In the treatment of Hepatocellular Carcinoma, the recommended dosage is 400 mg administered every 12 hours and in the treatment of thyroid cancer the recommended initial dosage is 400 mg, however, in the cases of toxicity, the doctor will monitor and change the dosage as needed. The median treatment during using this medication is a little over 5 months.

The wholesale cost of Sorafenib

Sorafenib is an expensive medication. In the USA, the consumers have to pay for, Nexvar oral tablet 200 mg, around $20,870 for a supply of 120 tablets. In Europe, a year’s treatment costs $57,232 in the UK but much lower, at $49,715 in Spain, and lower still, $44,543 in France. Given the high cost and it life-saving nature, many countries in the develop world subsidize or refund the cost of this treatment.
In India, Bayer sold a month's supply, 120 tablets for US$3,900. However, the Indian Patent Office granted Natco Pharma a license to manufacture generic Sorafenib 2012, this resulting in the price coming down by 97%.

How does Sorafenib work?

Sorafenib is a kinase inhibitor .Sorafenib blocks tumor cell growth in many ways. Its actions in the body stop the signals that tell cancer cells to grow while also preventing cancer cells from forming new blood vessels, thus stopping their growth. Sorafenib does only target enzymes on the surface of cancer cells but also within the cell. Many of these targets are involved in the making of blood vessels. After getting the desired information using targeted therapy, it is used to create a targeted therapy to attack the cancer cells without damaging the normal cells.

Finding Sorafenib Manufacturers and Suppliers

The process of finding trusted Sorafenib manufacturers and Sorafenib suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities.
The robust search engine makes it convenient to search for manufacturers and suppliers of Sorafenib. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.

We use cookies to offer you a better user experience, provide special features or analyze anonymous traffic data. Find out more about how we use cookies .